10-Q: Corvel Reports Strong Q1 Growth, Net Income Up 26%

Corvel Corporation announced a robust first quarter for fiscal year 2026, with revenues increasing 11% and net income rising 26.2% year-over-year, driven by new customer acquisition and enhanced bill review services.

Summary

• Revenues for the three months ended June 30, 2025, increased by $23.0 million, or 11%, to $234.7 million, compared to $211.7 million in the prior year period.
• Net income for the quarter rose by $5.7 million, or 26.2%, to $27.2 million, up from $21.6 million in the same period last year.
• Diluted earnings per share increased by $0.10, or 23.8%, to $0.52 per share, compared to $0.42 per share in the prior year.
• Gross profit improved to 24.2% of revenue for the quarter, up from 22.7% in the prior year period.
• Net cash provided by operating activities increased by $14.6 million to $55.0 million for the three months ended June 30, 2025.
• Cash and cash equivalents increased by $31.4 million to $202.0 million as of June 30, 2025, from $170.6 million at March 31, 2025.
• The company repurchased 87,105 shares of common stock for approximately $9.6 million during the quarter, at an average price of $110.01 per share.
• Network solutions services revenue increased by 21% to $87.9 million, primarily due to new customers and growth with existing customers in enhanced bill review.
• Patient management services revenue increased by 5.5% to $146.8 million.

Sentiment

Score: 8

Explanation: The company reported strong financial performance with double-digit growth in revenue, net income, and EPS, coupled with improved margins and robust cash flow from operations. The ongoing share repurchase program also indicates confidence in future performance and commitment to shareholder returns. While risks are present, the current quarter's results are highly positive.

Positives

• Total revenues increased by 11% year-over-year, demonstrating strong top-line growth.
• Net income grew by 26.2%, indicating improved profitability and operational efficiency.
• Diluted earnings per share increased by 23.8%, reflecting enhanced shareholder value.
• Gross profit margin expanded to 24.2% from 22.7%, showing better cost management relative to revenue.
• Net cash provided by operating activities significantly increased by $14.6 million, strengthening liquidity.
• Cash and cash equivalents increased by $31.4 million, providing a robust financial position.
• Network solutions services experienced substantial growth of 21%, driven by new customer acquisition and enhanced bill review.
• General and administrative expenses as a percentage of revenue decreased to 9.2% from 9.5%, indicating improved efficiency in overhead management.

Negatives

• Net cash used in investing activities increased by $7.8 million to $15.5 million, primarily due to increased spending on developed software and software license purchases.
• Net cash used in financing activities increased by $1.7 million to $8.1 million, mainly due to a decrease in proceeds from stock option exercises.
• General and administrative expenses increased by 7% year-over-year, primarily due to higher legal and insurance expenses.

Risks

• Sequential revenue may not increase and could decline, potentially causing the common stock price to fall below investor expectations.
• Inability to grow the business internally or through strategic acquisitions may hinder execution of the business plan and ability to address competitive challenges.
• Failure to increase market share among national and regional insurance carriers and large, self-funded employers could adversely affect results.
• Increased competition from national managed care providers, PPOs, TPAs, and insurance companies could lead to declining growth and profits.
• Declines in referrals for patient management services, due to factors like fewer long-term disability cases or increased competition, could materially harm results.
• Declines in workers compensation claims, driven by a less labor-intensive economy and proactive injury prevention, could materially adversely impact operations.
• Payors reducing the amount of work they outsource could materially adversely affect results of operations.
• Healthcare providers becoming increasingly resistant to cost containment techniques may cause revenue from cost containment operations to decrease.
• Increased utilization of early intervention services by healthcare payors could negatively affect revenue from later-stage network and healthcare management services.
• Competition for staffing, particularly for qualified management and healthcare professionals, may increase labor costs and reduce profitability.
• Inflation risks could increase wages, benefits, and other costs, potentially reducing profitability if not passed on to clients.
• Sustained increases in employee benefits costs could materially reduce profitability.
• Introduction of new technologies or industry standards could render existing software products less competitive, obsolete, or unmarketable.
• Developing or implementing new or updated software products and services may take longer and cost more than expected.
• Inability to develop or acquire necessary IT resources, or disruptive technologies, could materially adversely affect the business.
• Failure to effectively apply technology and data analytics to drive client value or gain internal efficiencies could adversely affect operating results and client relationships.
• Dependence on key third-party vendors and partners for technology and other support poses risks if they fail to perform or cease working with the company.
• Failure to attract and retain qualified or key personnel, including Michael Combs, could have a material adverse effect.
• Loss of several customers in a short period, due to contract terminations, industry consolidation, or competitive pressures, could materially adversely affect results.
• Acquisitions of intangible assets may result in significant increases in goodwill, which could be subject to impairment charges.
• Natural disasters, severe weather, power loss, communications failures, or the resurgence of pandemics (like COVID-19) could materially adversely affect business operations.
• Cybersecurity attacks or other disruptions to IT systems could result in loss, theft, misuse, or unauthorized access of sensitive information, leading to reputational harm, litigation, or operational disruption.
• Exposure to possible litigation and legal liability, including claims for adverse medical consequences or allegations of practicing medicine, could adversely affect the business.
• Increased costs of professional and general liability insurance may have an adverse effect on profitability.
• Changes in government regulations, including licensing requirements and healthcare legislative reforms, could increase operational costs or reduce demand for services.
• Increasing regulatory focus on privacy issues and expanding privacy laws could impact business models and expose the company to increased liability.
• Increased regulatory scrutiny on the use of big data techniques, machine learning, and artificial intelligence could impact the business and expose it to increased liability.
• Costs of compliance with sustainability or other environmental, social responsibility, or governance (ESG) laws, regulations, or policies could adversely affect the business.
• The market price and trading volume of common stock may be volatile, potentially resulting in rapid and substantial losses for stockholders.
• The stock repurchase program may not enhance long-term stockholder value, could increase stock price volatility, and will diminish cash reserves.

Future Outlook

The company expects general and administrative expenses in future quarters to remain between 9% and 11% of revenues. Management believes current cash and cash equivalents, cash generated from operations, and proceeds from stock option exercises will be sufficient to meet cash requirements for at least the next 12 months and beyond, including existing obligations, share repurchases, new service introductions, and healthcare service development. Share repurchases may be reduced or eliminated if income or cash flows decline.

Management Comments

• Revenues increased primarily from an increase in patient management and network solutions activity with new customers.
• The increase in cost of revenues was primarily due to the increase in total revenues of 11% and a 4.2% increase in salaries resulting from a 3.9% increase in average headcount to manage increased business volume.
• The increase in general and administrative expense was primarily due to the increase in total revenues of 11%, specifically due to an increase in legal and insurance expenses.
• The increase in diluted earnings per share was primarily due to an increase in net income.
• The increase in cash flow from operating activities was primarily due to the increase in net income, as well as an increase in accrued payroll due to the timing of the company's bi-weekly payroll.

Industry Context

The company operates in the managed care industry, providing services to payors of workers compensation, automobile insurance, and group health benefits. The Bureau of Labor Statistics reported a slight increase in occupational injury counts to 2.37 million in 2023 from 2.34 million in 2022, though still below pre-pandemic levels (2.69 million in 2019). Despite fewer claims historically, the company has offset this with increased market share. The industry faces considerable price competition, potential declines in workers compensation claims, and resistance from healthcare providers to cost containment techniques. The company's growth in network solutions, particularly enhanced bill review, aligns with the broader industry trend of seeking cost savings through efficient medical expense management.

Legal Proceedings

• The company is involved in various legal proceedings, disputes, and other claims arising in the ordinary course of business.
• No material loss is considered probable or reasonably estimable for any current legal proceedings, disputes, or other claims.

Related Party Transactions

• On May 28, 2025, Corstar Holdings, Inc., whose president, chief executive officer, and sole director is Jeffrey Michael (a director of Corvel Corporation), adopted a Rule 10b5-1 trading arrangement to sell up to 120,000 shares of the company's common stock over a period ending March 31, 2026.

Stakeholder Impact

• Shareholders: Benefited from a three-for-one forward stock split, increased diluted EPS, and ongoing share repurchases, but face risks of stock price volatility and potential dilution from future equity financing.
• Employees: Increased average headcount by 3.9% to manage business volume, but face competition for staffing and inflation risks impacting wages and benefits.
• Customers: Benefited from new customer acquisition and growth in enhanced bill review services, but face potential impacts from healthcare providers' resistance to cost containment and changes in outsourcing practices.
• Creditors: The company's strong cash position and operating cash flow indicate a healthy ability to meet existing obligations.
• Suppliers/Vendors: The company's increased spending on developed software and software licenses suggests continued engagement, but dependence on key third-party vendors is a noted risk.

Next Steps

• Continue to develop and introduce new services.
• Continue to develop healthcare-related services.
• Potentially repurchase additional shares of common stock under the existing stock repurchase program, subject to earnings and cash flow levels.

Key Dates

Recommendation

The company delivered exceptional financial results for the quarter, with significant double-digit growth in revenue, net income, and EPS, coupled with an expanding gross profit margin. The robust increase in operating cash flow and a healthy cash balance provide strong liquidity and financial flexibility. The ongoing share repurchase program demonstrates management's confidence and commitment to returning capital to shareholders. While the industry faces competitive and regulatory risks, Corvel's ability to gain market share and grow its network solutions services, particularly in enhanced bill review, positions it favorably. The strong performance across key metrics suggests continued positive momentum, making it an attractive investment.

Keywords

Managed care, Workers compensation, Healthcare cost containment, Network solutions, Patient management, Claims administration, Medical bill review, Third-party administrator, Insurance services, Risk management, Cybersecurity, Financial results, Stock repurchase, Q1 2026